Future Oncology · 2021 · 51 citations · 37 references
MedicineOncologySurgeryChemotherapyMetastasisSurgical OncologyCancer Survival AnalysisConcurrent ChemoradiationEsophageal CancerMalignant NeoplasmsNeoadjuvant ChemotherapyNeoadjuvant TherapyDistant Nodal MetastasisNeoadjuvant ChemoradiationNeoadjuvant ChemoradiotherapyNeoadjuvant Clinical TrialsNeoadjuvant Therapy TrialsR0 ResectionSurvival Benefit AssessmentSystematic Literature Review
Objectives: To identify the effective approach between neoadjuvant chemotherapy (NCT) and chemoradiotherapy (NCRT) by comparing patient survival and complications. Methods: A systematic literature search of articles published between January 1980 and October 2020 was conducted. Data were extracted and analyzed with STATA 12.0. Results: Five randomized trials and 15 retrospective studies, including 4529 patients (NCT: 2035; NCRT: 2494), were enrolled. Compared with NCT, NCRT provided a higher 3-year survival benefit, higher R0 resection and pathological complete response rates and lower local recurrence and distant metastasis rates, but no increase in 5-year survival. Perioperative mortality and cardiovascular complications were more common in patients with adenocarcinoma. Conclusions: Further studies should concentrate on identifying the optimal neoadjuvant approach and suitable beneficiaries.
37
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.6K citations
Nobutoshi Ando, Hoichi Kato, Hiroyasu Igaki et al. · Annals of Surgical Oncology · 2011 · 1.4K citations